Human malignant melanoma cells release a factor that inhibits the expression of smooth muscle α-actin

Journal of Dermatological Science

Volumn 23, Issue 3, 2000, Pages 170-177

  Okamoto Inoue, M ^a   Nakayama, J ^b   Hori, Y ^c   Taniguchi, S ^d  

^a KURUME UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c ASO IIZUKA HOSPITAL   (Japan)

^d Angio Research Division   (Japan)

Author keywords

Cytoskeletal protein; Myofibroblast; Pericyte; Platelet derived growth factor

Indexed keywords

ALPHA ACTIN;

ARTICLE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MELANOMA; MELANOMA CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION;

ACTINS; ANIMALS; CULTURE MEDIA, CONDITIONED; HUMANS; MELANOMA; MUSCLE, SMOOTH, VASCULAR; NEOPLASM PROTEINS; RATS; TUMOR CELLS, CULTURED;

EID: 0033839466     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(00)00072-4     Document Type: Article

References (40)

1. Halaban R., Miglarese M.R., Smicun Y. et al. Melanomas, from the cell cycle point of view. Int. J. Mol. Med. 1:1998;1419-1425.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31.
3. Duffy M.J. Proteases as prognostic markers in cancer. Clin. Cancer Res. 2:1996;613-618.
4. Friedman E., Verderame M., Winawer S. et al. Actin cytoskeletal organization loss in the benign-to-malignant tumor transition in cultured human colonic epithelial cells. Cancer Res. 44:1984;3040-3050.
5. Leavitt J., Bushar G., Kakunaga T. et al. Variations in expression of mutant β-actin accompanying incremental increases in human fibroblast tumorigenicity. Cell. 28:1982;259-268.
6. Sadano H., Taniguchi S., Baba T. Newly identified type of β-actin reduces invasiveness of mouse B16-melanoma. FEBS Lett. 271:1990;23-27.
7. Shimokawa-Kuroki R., Sadano H., Taniguchi S. A variant actin (βm) reduces metastasis of mouse B16 melanoma. Int. J. Cancer. 56:1994;689-697.
8. Taniguchi S., Inoue M., Nakayama J. et al. Differential expression of smooth muscle α-like actin between benign and malignant human pigment tissues. Cancer Lett. 47:1989;29-36.
9. Skalli O., Pelte M.-F., Peclet M.-C. et al. α-Smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J. Histochem. Cytochem. 37:1989;315-321.
10. Reynolds A.J., Chaponnier C., Jahoda C.A.B. et al. A quantitative study of the differential expression of α-smooth muscle actin in cell populations of follicular and non-follicular origin. J. Invest. Dermatol. 101:1993;577-583.
11. Skalli O., Ropraz P., Trzeciak A. et al. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 103:1986;2787-2796.
12. Darby I., Skalli O., Gabbiani G. α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 63:1990;21-29.
13. Leavitt J., Gunning P., Kedes L. et al. Smooth muscle α-actin is a transformation-sensitive marker for mouse NIH 3T3 and Rat-2 cells. Nature. 316:1985;840-842.
14. Okamoto-Inoue M., Taniguchi S., Sadano H. et al. Alteration in expression of smooth muscle α-actin associated with transformation of rat 3Y1 cells. J. Cell Sci. 96:1990;631-637.
15. Clowes A.W., Clowes M.M. et al. Arterial smooth muscle cells in vivo: relationship between actin isoform expression and mitogenesis and their modulation by heparin. J. Cell Biol. 107:1988;1939-1945.
16. Blank R.S., Thompson M.M., Owens G.K. Cell cycle versus density dependence of smooth muscle α actin expression in cultured rat aortic smooth muscle cells. J. Cell Biol. 107:1988;299-306.
17. Corjay M.H., Tompson M.M., Lynch K.R. et al. Differential effect of platelet-derived growth factor versus serum-induced growth on smooth muscle α-actin and non-muscle β-actin mRNA expression in cultured rat aortic smooth muscle cells. J. Biol. Chem. 264:1989;10501-10506.
18. Blank R.S., Owens G.K. Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. J. Cell. Physiol. 142:1990;635-642.
19. Tsukamoto H., Mishima Y., Hayashibe K. et al. α-Smooth muscle actin expression in tumor and stromal cells of benign and malignant human pigment cell tumors. J. Invest. Dermatol. 98:1992;116-120.
20. Tsuchida T., Ravindranath M.H., Saxton R.E. et al. Gangliosides of human melanoma: altered expression in vivo and in vitro. Cancer Res. 47:1987;1278-1281.
21. Sappino A.-P., Skalli O., Jackson B. et al. Smooth muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer. 41:1988;707-712.
22. Czernobilsky B., Shezen E., Lifschitz-Mercer B. et al. smooth muscle actin (α-SM actin) in normal human ovaries, in ovarian stromal hyperplasia and in ovarian neoplasms. Virchows Arch. B Cell Pathol. 57:1989;55-61.
23. Cintorino M., de Marco E.B., Leoncini P. et al. Expression of α-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes. Int. J. Cancer. 47:1991;843-846.
24. Leoncini P., Cintorino M., Vindigni C. et al. Distribution of cytoskeletal and contractile proteins in normal and tumour bearing salivary and lacrimal glands. Virchows Arch. A Pathol. Anat. Histopathol. 412:1988;329-337.
25. Kobayashi H., Tsuruchi N., Sugihara K. et al. Expression of α-smooth muscle actin in benign or malignant ovarian tumors. Gynecol. Oncol. 48:1993;308-313.
26. Inoue M., Nakayama J., Urabe A. et al. Malignant schwannoma in a case of type 1 neurofibromatosis with decreased immunoreactivity of smooth muscle α-actin in tumor vessels. J. Dermatol. Sci. 8:1994;157-161.
27. Schlingemann R.O., Rietveld F.J.R., Kwaspen F. et al. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138:1991;1335-1347.
28. Owens G.K., Loeb A., Gordon D. et al. Expression of smooth muscle-specific α-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J. Cell Biol. 102:1986;343-352.
29. Desmouliere A., Geinoz A., Gabbiani F. et al. Transforming growth factor-β1 induce α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122:1993;103-111.
30. Barnhill R.L., Xiao M., Graves D. et al. Expression of platelet-derived growth actor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo. Br. J. Dermatol. 135:1996;898-904.
31. Albino A.P., Davis B.M., Nanus D.M. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res. 51:1991;4815-4820.
32. Ronnov-Jessen L., Petersen O.W. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Lab. Invest. 68:1993;696-707.
33. Leof E.B., Proper J.A., Goustin A. et al. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci. USA. 83:1986;2453-2457.
34. Hansson G.K., Hellstrand M., Rymo L. et al. Interferon γ inhibits both proliferation and expression of differentiation-specific α-smooth muscle actin in arterial smooth muscle cells. J. Exp. Med. 170:1989;1595-1608.
35. Van de Berg J.S., Rudolph R., Woodward M. Comparative growth dynamics and morphology between cultured myofibroblasts from granulation wounds and dermal fibroblasts. Am. J. Pathol. 114:1984;187-200.
36. Okamoto-Inoue M., Nakayama J., Taniguchi S. et al. Vascularity in neurofibromas demonstrated by immuno-staining of smooth muscle α-actin. Ishibashi Y., Hori Y. Tuberous Sclerosis and Neurofibromatosis: Epidemiology, Pathopysiology, Biology and Management. 1990;93-99 Elsevier, Amsterdam.
37. Fool T.H., Naylor I.L., Timmons M.J. et al. Intracellular actin as a marker for myofibroblasts in vitro. Lab. Invest. 67:1992;727-733.
38. Morelli J.G., Yohn J.J., Zekman T. et al. Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J. Invest. Dermatol. 101:1993;605-608.
39. Barsky S.H., Gopalakrishna R. Increased invasion and spontaneous metastasis of B16 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice. Cancer Res. 47:1987;1663-1667.
40. Shaw R.F., Doherty D.E., Ritter A.G. et al. Adherence-dependent increase in human monocyte PDGF(B) mRNA is associated with increases in c-fos, c-jun, and EGF2 mRNA. J. Cell Biol. 111:1990;2139-2148.